Multidrug Resistant Tuberculosis: Difficulties Faced DuringTreatment
Abstract
Objective: Present study was undertaken to observe the personal, social and environmental difficulties of MDR TB patients during treatment on a programmatic management of drug resistant TB site.Methods
This cross-sectional study was undertaken at PHRC TB Research Laboratory and PMDT site, King Edward st st Medical University/Mayo Hospital, Lahore, from January 1 to May 31 , 2021. Confirmed MDR-TB patients seeking treatment were included in this study after taking informed consent. Pre-designed proforma containing information about demography, socio-economic status, transportation issues, attitude of healthcare staff, social stigma, provision of support from PMDT site and side effects of treatment was used for data collection. Data was entered and analysed in statistical package for social science (SPSS) software.Results
A total of 100 MDR-TB patients taking treatment from Programmatic Management of Drug-Resistant Site (PMDT) were interviewed that included 42% males and 58% females. Patients had to travel an average distance of 45.4±42.2 km with a range of 2-215 km to reach the PMDT site. Patients had to spend a mean amount of 818±1206 rupees to reach the hospital and spend about 400±150 rupees to take meals during traveling. Attitude problems from household and in laws were also observed among 13% patients most of which (10%) were females. Joint pain was the most dominant adverse drug effect and was reported by 48% respondents, followed by nausea 46%, weakness 36%, irritability 28% and vision problems in 15% of the patients.Conclusion
Problems of MDR-TB patients include long travelling distances, insufficient financial support and troublesome side effects of second line anti TB drugs. In addition to these, misbehaviour and neglect from the spouse and in laws, belief in religious and spiritual treatments, exploitation by homeopaths, hakims and quacks are other issues that must be focused on and addressed properly.Keywords:
Multidrug resistant TB, Problems, Side Effects, Incidence.Published
2025/08/23
Issue
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments psimjournal@gmail.com